Company Name : Caplin Point Laboratories Ltd.
Address : No. 3, Lakshmanan Street, T. Nagar, Chennai – 600 017, Tamil Nadu, India
Tel No: 91 44 2815 6653, 2815 6905
Email : jayapal@caplinpoint.net, bms@caplinpoint.net
Website : http://caplinpoint.net/
Company Profile
The genesis of Caplin Point took place in the year 1990 as a Private Limited company mainly to manufacture a wide range of Ointments, Creams and other External applications in addition to the regular segments of pharmaceutical formulations. In 1994, Caplin Point was converted into a Public Limited company and the public issue was successfully oversubscribed by 117 times which is a record in the Pharmaceutical industry in India. The entire proceeds of the public issue were deployed in the manufacturing facility and then translated into a state of the art factory at Pondicherry spanning 51,000 sq. ft.
With the merger of May (India) laboratories P Ltd, Chennai in 2006 and Malind Laboratories P Ltd, Baddi in 2009, Caplin Point had substantially increased its production capacity to cope up with the growing demands of the markets. We are also one of the early entrants in India in the area of Biotechnology. Caplin Point has already started constructing its latest and largest project, a facility that would be in compliance with US FDA, UK MHRA, and other regulatory bodies for multiple dosage forms such as liquid injectables, ophthalmic drugs and lyophilized bio-tech products.
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…